Unilever manufactures and sells detergents, personal care products, and foods under brands including Dove, Lipton, Hellmann's, and Ben & Jerry's across 190 countries. The company's scale and distribution network create structural advantages in negotiating with retailers and achieving shelf space that smaller competitors cannot replicate. Revenue growth has stalled at 0.5% annually, but the business generates substantial cash: operating margins sit at 20.3% with a 31.9% return on equity, and the forward PE of 16.4 reflects the market's skepticism about near-term acceleration. The valuation offers limited margin of safety given that growth is absent and the company faces persistent pressure from private label and direct-to-consumer brands in developed markets. At current prices, the stock appears to price in a continuation of low single-digit growth rather than a meaningful reacceleration, leaving little room for disappointment.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 21 Oct 2026, 13:04 CEST | Rating | Fairly valued | first publication | $65.22 |
| 18 Oct 2026, 01:52 CEST | ACCE price target | $71.00 | $63.00 | $66.16 |
| 17 Oct 2026, 00:00 CEST | Fair value | $69.48 | $67.12 | $64.65 |
| 12 Oct 2026, 00:00 CEST | Fair value | $67.12 | $50.88 | $62.26 |
| 9 Oct 2026, 00:00 CEST | Fair value | $50.88 | $52.12 | $54.56 |
| 6 Oct 2026, 00:00 CEST | Fair value | $52.12 | $52.97 | $53.18 |
| 2 Oct 2026, 00:00 CEST | Fair value | $52.97 | $53.62 | $53.48 |
| 27 Sept 2026, 00:00 CEST | Fair value | $53.62 | $52.89 | $54.85 |
| 20 Sept 2026, 00:00 CEST | Fair value | $52.89 | $53.53 | $53.94 |
| 17 Sept 2026, 00:00 CEST | ACCE price target | $63.00 | first publication | $62.44 |
Answered from Unilever PLC American Depositary Shares (each representing One Ordinary Share) fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| UL Unilever PLC American Depositary Shares (each representing One Ordinary Share) | $66.23 | $70 | 5% below | 13.0x | 31.9% | 75 | 57 |
| UNA.AS Unilever PLC | €59.02 | €60 | 2% below | 13.9x | 31.9% | 75 | 60 |
| ULVR.L Unilever | £49.38 | £38 | 29% above | 13.4x | 31.9% | 75 | 56 |
| OR.PA L'Oreal | €436.30 | €213 | 105% above | 37.0x | 19.4% | 84 | 57 |
| CL Colgate-Palmolive Company Common Stock | $94.04 | $71 | 32% above | 37.0x | 267.4% | 72 | 56 |
| PG Procter & Gamble Company (The) Common Stock | $161.02 | $106 | 52% above | 24.3x | 30.3% | 85 | 60 |
| RKT.L Reckitt Benckiser Group plc | £55.36 | £61 | 9% below | 12.5x | 48.0% | 83 | 58 |
Where UL ranks against its sector peers on each metric.